
Evaluate Vantage 2021 Preview: High Hopes and Valuations Set the Tone for Biopharma
LONDON, BOSTON, & TOKYO–(BUSINESS WIRE)–#COVID19–COVID-19 will continue to be a defining issue for pharma and biotech companies in 2021, but overall the sector will start […]
